Afrinome Test Kit
Afrinome PGx testing provides insights into the relationship between a patient's unique genetic profile and their response to specific medications.

 

Afrinome Individual DNA Profiling
Private individuals may also choose to obtain records of their DNA profiles in case identification is ever needed.

 

Afrinome Paternity Test
DNA paternity test determines whether a tested man is the biological father of a tested child.

​

Afrinome PGx test benefit:

 

Optimized Dosing & Efficacy
Pharmacogenetics testing identifies patients who could be responsive or non-responsive to treatment, develop interactions, experience unwanted side effects, or require dosing adjustment. Understanding your patient’s genetics may lead to more informed prescribing decisions.

Reduced Trial & Error Prescribing
The Clinical Pharmacogenetics Implementation Consortium (www.CPICPgx.org provides peer-reviewed guidelines of how to use pharmacogenetic information. The Rxight program utilizes CPIC guidelines and FDA labeling.

Reduced Risk of Adverse Drug Reactions (ADR’s)
The ongoing benefits of pharmacogenetic testing include a decreased cost in both hospitalizations and healthcare treatment due to the avoidance of ineffective therapies or severe side effects with tailored medical treatment. In fact, most pharmaco-economic studies support pharmacogenetic testing as a cost-effective and cost-saving strategy.

​

 

Achieving Desired Therapeutic Benefits for Improved Patient Outcomes
The FDA has incorporated pharmacogenetics information into drug labels and now offers a table of drugs linked to genetic biomarkers emphasizing the importance of pharmacogenetics for personalized medicine.